Figure 6.
Overall survival from randomization among patients requiring baseline RBC transfusions. Data presented among patients on pacritinib and BAT requiring RBC transfusions at baseline.

Overall survival from randomization among patients requiring baseline RBC transfusions. Data presented among patients on pacritinib and BAT requiring RBC transfusions at baseline.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal